TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 DKK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
24,596
|
28,935
|
29,607 |
Financial expenses |
45
|
104
|
521 |
Earnings before taxes |
559
|
1,319
|
1,056 |
EBITDA |
381
|
1,424
|
1,086 |
Total assets |
46,068
|
37,058
|
32,536 |
Current assets |
46,068
|
37,058
|
32,536 |
Current liabilities |
20,055
|
12,072
|
7,816 |
Equity capital |
26,013
|
24,986
|
24,720 |
- share capital |
164
![]() |
164
|
163 |
Employees (average) |
16
![]() |
16
|
18 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
56.5%
|
67.4%
|
76.0% |
Turnover per employee |
1,537
|
1,808
|
1,645 |
Profit as a percentage of turnover |
2.3%
|
4.6%
|
3.6% |
Return on assets (ROA) |
1.3%
|
3.8%
|
4.8% |
Current ratio |
229.7%
|
307.0%
|
416.3% |
Return on equity (ROE) |
2.1%
|
5.3%
|
4.3% |
Change turnover |
-3,749
|
1,751
|
-4,947 |
Change turnover % |
-13%
|
6%
|
-14% |
Chg. No. of employees |
0
|
-2
|
-1 |
Chg. No. of employees % |
0%
|
-11%
|
-5% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.